Back

Is unsatisfactory outcome of alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy predictable?

30 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Dennis Lawin

University Clinic OWL, Bielefeld (Germany)

8 More presentations in this session

Presentation thumbnail
Epidemiology and prognosis of obstructive and non-obstructive hypertrophic cardiomyopathy in Finland: a nationwide cohort study
Assistant Professor M. Laine (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Non-invasive assessment of left ventricular hemodynamic forces in hypertrophic cardiomyopathy
Doctor G. Panichella (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Functional capacity by cardiopulmonary exercise testing is not related to health status in obstructive hypertrophic cardiomyopathy
Doctor L. Bjerregaard (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
Hemodynamic effects of right and biventricular pacing during exercise in hypertrophic obstructive cardiomyopathy
Doctor T. Ahmed (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Evaluation of clinical need, effectiveness, and safety of the first myosin inhibitor mavacamten in real world patients
Doctor L. Seuthe (Cologne, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock

The Event

Event poster

ESC Congress 2024

30 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Transcatheter intervention in hypertrophic obstructive cardiomyopathy
thumbnail
Congress Presentation
Effect of alcohol septal ablation on exercise hemodynamics, symptoms and quality of life in patients with obstructive hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Radiofrequency septal ablation as a therapeutic option in refractory obstructive hypertrophic cardiomyopathy to myectomy: a case series

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources